Clinical trial
BMS-599626 in Treating Patients With Metastatic Solid Tumors
NCT00093730 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00093730 |
|---|---|
| Title | BMS-599626 in Treating Patients With Metastatic Solid Tumors |
| Official title | Phase I Study Of BMS-599626 In Patients With Advanced Solid Malignancies That Express Her2 |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | BMS-59926 |
| Enrollment | 9 |
| Start date | Aug 1, 2004 |
| Primary completion | Apr 1, 2006 |
| First posted | Oct 8, 2004 |
| Last update posted | Oct 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: